Navigation Links
Einstein & Montefiore present research at American Diabetes Association Scientific Sessions
Date:6/9/2014

June 9, 2014 (BRONX, NY) Investigators at Albert Einstein College of Medicine of Yeshiva University and Montefiore Medical Center will present their latest research at the American Diabetes Association's 74th Scientific Sessions. Einstein-Montefiore scientists and clinicians are participating in nearly three dozen presentations, sessions and symposia during the five-day meeting. They will address a range of basic, translational and clinical research topicsfrom medication adherence in adolescents and the impact on resveratrol and vitamin D on insulin resistance to epigenetic and genetic triggers for the disease. ADA will takes place June 13-17 at the Moscone Center in San Francisco, California.

Among the highlights are symposia featuring:

  • Jill Crandall, M.D., professor of clinical medicine at Einstein and attending physician, endocrinology at Montefiore, on the most recent findings from the ongoing Diabetes Prevention Program Outcomes Study (Mon., June 16 at 8:00 a.m.)

  • Maureen Charron, Ph.D., professor of biochemistry at Einstein, on the role of glucagon in metabolic homeostasis (Fri., June 13 at 2:00 p.m.)

  • Rajat Singh, M.D., assistant professor of medicine at Einstein, on the role of autophagy in diabetes (Sat., June 14 at 2:15 p.m.)

  • Judith Wylie-Rosett, Ed.D., division head, health promotion and nutrition research, department of epidemiology and population health at Einstein, on better approaches to counseling weight loss among obese patients (Tues., June 17 at 7:30 a.m.)

Poster and oral presentations will include:

  • Vitamin D Repletion Reduces Adipose Tissue Fibrosis and Improves Insulin. Oral presentation by Akankasha Goyal, M.D., a research fellow in the lab of Meredith Hawkins, M.D., professor of medicine at Einstein and attending physician, endocrinology at Montefiore. Abstract #OR-90, IA-OR02: Adipose Tissue Development and Metabolic Signaling. Sat., June 14, 8:00-10:00 a.m. W-2002 (West Building)

  • Distress and Diabetes Treatment Adherence: A Mediating Role for Perceived Control in Adults with Type 2 Diabetes. Poster presented by Jeffrey S. Gonzalez, Ph.D., assistant professor of medicine and epidemiology & population heath at Einstein. Poster #822, GPS01: Saturday General Poster Session. Sat., June 14, 11:30 a.m.-1:30 p.m. Poster Hall (Hall D-North)

  • Resveratrol Improves Insulin Resistance without Affecting Muscle Mitochondria in Overweight Humans. Oral presentation by Roger Maginley, M.D., a research fellow in the lab of Dr. Hawkins. Abstract #144, AC-OR05: Hypoglycemia Brain, Muscle, Heart and Opioids. Sun., June 15, 8:00-10:00 a.m., N-132 (North Building)

  • Relationship of Self-Esteem to Glycemic Control amongst Minority Adolescents with Type 1 Diabetes. Poster presented by Joslyn Kenowitz, Ph.D. student in lab of Dr. Gonzalez, working in collaboration with Rubina Heptulla, M.B.B.S., chief of pediatric endocrinology at Einstein and Montefiore. Poster #64-LB, Late Breaking Poster Session. Sun., June 15, 12:00-2:00 p.m., Poster Hall (Hall D-North)

  • Exposure to a Maternal High Fat Milieu Alters Hepatic and White Adipose Epigenome in Mice. Poster presented by Maureen Charron, Ph.D., professor of biochemistry at Einstein. Poster #1806, GPS03: Monday General Poster Session. Mon., June 16, 12:00-2:00 p.m., Poster Hall (Hall D-North).

  • FTO Genetic Variants, Dietary Intakes, and Adiposity: Results from Over 16,000 Children and Adolescents. Oral presentation by Qibin Qi, Ph.D., assistant professor of epidemiology and population health at Einstein. Abstract #382-OR, CT-OR14: ADA Presidents Oral Session. Tues., June 17, 9:45-11:45 a.m., N-134 (North Building)

Einstein-Montefiore investigators are available to speak about their research and other topics of interest upon request.


'/>"/>

Contact: Deirdre Branley
sciencenews@einstein.yu.edu
718-430-3101
Albert Einstein College of Medicine
Source:Eurekalert

Related medicine news :

1. Feinstein Institute researcher publishes new perspective on sepsis
2. Einstein helps establish $28 million consortium to find ebola treatment
3. Registration open for the Weinstein Cardiovascular Conference
4. Feinstein Institute Researcher Joins International Partnership in Neuroscience Research
5. Feinstein Institute researchers show a genetic overlap in schizophrenia and cognitive ability
6. Feinstein Researcher Receives 2013 Best of Manhasset Award
7. Feinstein Institute Encourages Science Education for NY Area Middle and High School Students
8. Einstein researchers lead panels at NIH Aging and Chronic Disease Symposium on Geroscience
9. How does aging affect cancer? Einstein awarded $2.8m grant to answer NCI provocative question
10. Albert Einstein Cancer Center begins 40th year of continuous NIH support with $17 million grant
11. Feinstein Institute Researcher Organizes LI Alzheimer’s Consortium
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/27/2016)... ... 2016 , ... "FCPX editors can now reveal their media with growing colorful ... Christina Austin - CEO of Pixel Film Studios. , ProSlice Color brings the ... can now reveal the media of their split screens with growing colorful panels. , ...
(Date:6/27/2016)... KS (PRWEB) , ... June 27, 2016 , ... TopConsumerReviews.com ... retailers of Eyeglasses . , Millions of individuals in the United States and ... have become a way to both correct vision and make a fashion statement. Even ...
(Date:6/26/2016)... ... June 26, 2016 , ... PawPaws brand pet supplements ... that was developed to enhance the health of felines. The formula is all-natural and ... main herbs in the PawPaws Cat Kidney Support Supplement Soft Chews are ...
(Date:6/25/2016)... ... June 25, 2016 , ... Austin residents seeking Mohs surgery ... of Mohs Surgery and to Dr. Russell Peckham for medical and surgical dermatology. , ... for skin cancer. The selective fellowship in Mohs Micrographic Surgery completed by Dr. Dorsey ...
(Date:6/25/2016)... ... 2016 , ... As a lifelong Southern Californian, Dr. Omkar Marathe earned his ... David Geffen School of Medicine at UCLA. He trained in Internal Medicine at Scripps ... in hematology/oncology at the UCLA-Olive View-Cedars Sinai program where he had the opportunity to ...
Breaking Medicine News(10 mins):
(Date:6/26/2016)... June 27, 2016  VMS Rehab Systems, Inc. ( ... take whatever measures required to build a strong and ... is currently listed on the OTC Markets-pink current trading ... and CEO, "We are seeing an anomaly in market ... not only by the Company, but shareholders and market ...
(Date:6/24/2016)... SOUTH SAN FRANCISCO, Calif. , June 24, ... GBT ), a biopharmaceutical company developing novel ... with significant unmet needs, today announced the closing ... 6,400,000 shares of common stock, at the public ... the shares in the offering were offered by ...
(Date:6/24/2016)... Va. , June 24, 2016 The ... set of recommendations that would allow biopharmaceutical ... (HCEI) with entities that make formulary and coverage decisions, ... the "value" of new medicines. The recommendations ... does not appear on the drug label, a prohibition ...
Breaking Medicine Technology: